122 related articles for article (PubMed ID: 11911299)
1. Chemoradiation for patients with esophageal cancer aged 80 and older.
Uno T; Kawakami H; Funami Y; Isobe K; Yasuda S; Aruga T; Shimada H; Okazumi S; Nabeya Y; Mastubara H; Ochiai T; Ito H
Anticancer Res; 2001; 21(6A):4095-7. PubMed ID: 11911299
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and toxicities of concurrent chemoradiation for elderly patients with esophageal cancer.
Uno T; Isobe K; Kawakami H; Ueno N; Kobayashi H; Shimada H; Mastubara H; Okazumi S; Nabeya Y; Shiratori T; Ochiai T; Kawata T; Ito H
Anticancer Res; 2004; 24(4):2483-6. PubMed ID: 15330202
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
4. [Long-term results of chemoradiation therapy for the patients with locally advanced (T4) esophageal cancer].
Sekikawa K; Onogi H; Yazawa T; Sato Y; Sakamoto W; Miyamoto K; Fujita S; Suzuki S; Endo Y; Ohki S; Takenoshita S
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1253-6. PubMed ID: 16969020
[TBL] [Abstract][Full Text] [Related]
5. A case of complete response to esophageal cancer by a novel concurrent chemoradiation therapy.
Shimoyama S; Aoki F; Kojima J; Kaminishi M
Hepatogastroenterology; 1999; 46(28):2409-13. PubMed ID: 10522007
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
Maurel J; Cervantes A; Conill C; Salazar R; Martin-Richard M; Pera M; Manzano H; Chirivella I; Gallego R; Marfa X
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):91-6. PubMed ID: 15850907
[TBL] [Abstract][Full Text] [Related]
7. [Radiotherapy combined with S-1 and cisplatin for locally advanced and metastatic esophageal cancer].
Iwase H
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():224-9. PubMed ID: 16898007
[TBL] [Abstract][Full Text] [Related]
8. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
9. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
10. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of daily concurrent chemoradiation therapy as nonsurgical management for esophageal cancer: our experience and theoretical background.
Shimoyama S; Aoki F; Murakami T; Toyoda K; Kaminishi M
J Surg Oncol; 2000 Jun; 74(2):134-7. PubMed ID: 10914823
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
14. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
Nakajima TE; Ura T; Ito Y; Kato K; Minashi K; Nihei K; Hironaka S; Boku N; Kagami Y; Muro K
Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671
[TBL] [Abstract][Full Text] [Related]
15. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
16. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
[TBL] [Abstract][Full Text] [Related]
17. Extended survival time for esophageal cancer patients treated with aggressive surgery and concurrent chemoradiation.
Saito T; Shigemitsu Y; Kinoshita T; Shimoda K; Katsuta T; Abe T; Chikuba K; Miyahara M; Kobayashi M
Int Surg; 1994; 79(2):93-7. PubMed ID: 7928159
[TBL] [Abstract][Full Text] [Related]
18. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma.
Morota M; Gomi K; Kozuka T; Chin K; Matsuura M; Oguchi M; Ito H; Yamashita T
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):122-8. PubMed ID: 19327900
[TBL] [Abstract][Full Text] [Related]
19. Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.
Seung SK; Smith JW; Molendyk J; Bader SB; Phillips M; Regan J; Louie J; Soo E; Seligman M; Ruzich J; Skokan L; Ross HJ
Semin Oncol; 2004 Dec; 31(6 Suppl 18):13-9. PubMed ID: 15726517
[TBL] [Abstract][Full Text] [Related]
20. [Cisplatin plus 5-fluorouracil combination therapy in the treatment of advanced esophageal cancer: a report of 156 cases].
Wang L; Li X; Wang R
Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):389-91. PubMed ID: 11776584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
